Fast, accurate, blood-based detection of mucosal healing
Gut-targeted small molecule inhibitors of GCPII for the treatment of IBD
Development of an adhesive filler that promotes rapid healing of perianal fistula
A novel strategy for controlling the sphingosine 1-phosphate pathway as a potential first-in-class treatment for IBD
First-in-class proprietary formulation of an endogenous immuno-resolvent for the treatment of IBD
E3 ligase inhibition to reduce multiple pathogenic pro-inflammatory mediators in Crohn’s disease
PAI-1 inhibitor for the treatment of IBD
Highly selective inhibitors of the chromatin reader BRD4 for the treatment of IBD
Rationally-defined bacterial consortia to restore a healthy gut bacterial ecosystem in IBD
Your Internet Explorer is outdated. For optimal security settings and a better experience on our site, try switching to one of these options:
Google Chrome
Firefox
Safari (macOS 10.8+ only)
